Hi-Clearance Inc. (TPEX:1788)
143.00
-1.00 (-0.69%)
May 13, 2025, 12:54 PM CST
Hi-Clearance Revenue
Hi-Clearance had revenue of 1.05B TWD in the quarter ending March 31, 2025, with 8.88% growth. This brings the company's revenue in the last twelve months to 4.16B, up 6.97% year-over-year. In the year 2024, Hi-Clearance had annual revenue of 4.07B with 4.54% growth.
Revenue (ttm)
4.16B
Revenue Growth
+6.97%
P/S Ratio
1.56
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.07B | 177.03M | 4.54% |
Dec 31, 2023 | 3.90B | -793.91M | -16.93% |
Dec 31, 2022 | 4.69B | 1.01B | 27.30% |
Dec 31, 2021 | 3.68B | 252.04M | 7.34% |
Dec 31, 2020 | 3.43B | 191.25M | 5.90% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.69B |
Lumosa Therapeutics | 43.59M |